Cargando…

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system

OBJECTIVE: To construct a high-titer Nipah pseudovirus packaging system using the HIV lentivirus backbone vector and establish a safe neutralization assay for Nipah pseudovirus in biosafety level 2 facilities. METHODS: Nipah virus (NiV) fusion protein (F) and glycoprotein (G) recombinant expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xiaoyi, Wang, Chao, Huang, Yiman, Cong, Shanshan, Tan, Jingjing, Hou, Wenzhe, Ma, Fenlian, Zheng, Lishu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860241/ https://www.ncbi.nlm.nih.gov/pubmed/36680637 http://dx.doi.org/10.1007/s10529-023-03351-5

Ejemplares similares

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Comprehensive virome analysis of the viral spectrum in paediatric patients diagnosed with Mycoplasma pneumoniae pneumonia
por: Guo, Qiong, et al.
Publicado: (2022)

Human adenoviruses in paediatric patients with respiratory tract infections in Beijing, China
por: Huang, Yiman, et al.
Publicado: (2021)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
por: Wang, Sheng, et al.
Publicado: (2022)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023)

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
por: Nie, Jianhui, et al.
Publicado: (2019)

Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants
por: Mi, Taotao, et al.
Publicado: (2022)

Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody
por: Xia, Ming, et al.
Publicado: (2023)

Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus
por: Qiu, Chao, et al.
Publicado: (2013)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
por: Ma, Fenlian, et al.
Publicado: (2023)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
por: Bi, Jinhao, et al.
Publicado: (2022)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
por: Chen, Pan, et al.
Publicado: (2017)

Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
por: Desheva, Yulia, et al.
Publicado: (2023)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Whole genome sequencing and evolution analyses of Human metapneumovirus
por: Wei, Tianli, et al.
Publicado: (2023)

Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay
por: Zhang, Huafei, et al.
Publicado: (2014)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022)

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Development and Evaluation of a Pseudovirus-Luciferase Assay for Rapid and Quantitative Detection of Neutralizing Antibodies against Enterovirus 71
por: Wu, Xing, et al.
Publicado: (2013)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Epidemiology and genotypic diversity of human metapneumovirus in paediatric patients with acute respiratory infection in Beijing, China
por: Wang, Chao, et al.
Publicado: (2021)

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
por: Neerukonda, Sabari Nath, et al.
Publicado: (2021)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD
por: Septisetyani, Endah Puji, et al.
Publicado: (2021)

The Immunobiology of Nipah Virus
por: Liew, Yvonne Jing Mei, et al.
Publicado: (2022)

Antibodies to Nipah or Nipah-like Viruses in Bats, China
por: Li, Yan, et al.
Publicado: (2008)

Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis
por: Izac, Jerilyn R., et al.
Publicado: (2023)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lmr7h3g5u6j4048v76veahch6o